Brought to you by:
‘Urgent action needed’ to improve implementation of guideline-directed medical therapy for PVI
Almost one-half of the patients receiving a peripheral vascular intervention (PVI) in the Society for Vascular Surgery (SVS) Vascular Quality Initiative (VQI) registry between 2017 and 2018 were not on guideline-directed medical therapy (GDMT). Kim G. Smolderen, PhD, and Carlos…
More than a research project: The vascular trainee’s role in tackling disparities in peripheral arterial disease
One of my earliest clinical experiences with vascular disease was as a high school student shadowing at a busy urban hospital in Detroit. A Black man with a longstanding history of diabetes developed a foot ulcer that ultimately required an…
The top 10 most popular Vascular Specialist stories of January 2023
In January 2023, most popular among the Vascular Specialist readers were several stories from the recent Southern Association for Vascular Surgery meeting, including a report of data shared to demonstrate the benefits of vascular involvement in non-vascular-led cases; an update on the use of the Human Acellular…
Patients with claudication receive more ‘aggressive’ surgical management in high-competition regions, study finds
Demonstrating the “susceptibility” of care delivery to regional market competition, M. Libby Weaver, MD, presented the case that intermittent claudication (IC) is a “novel and underdefined” driver of practice variation in management of patients at the 2023 Southern Association for…
VQI study leader highlights virtue of multispecialty gathering of best longitudinal data on PAD procedures
Daniel Bertges, MD, talks to Vascular Specialist about recent findings from his work investigating the IN.PACT Admiral drug-coated balloon (DCB). He related how they showed promising results in treating femoropopliteal in-stent restenosis in a Society for Vascular Surgery (SVS) Vascular…
Early data show ‘dramatic improvement’ in amputation-free survival after initiation of novel ‘Limb Alert’ for acute limb ischemia
This advertorial is sponsored by Tampa General Hospital. In cases of acute limb ischemia (ALI), time is of the essence, says Charles J. Bailey, MD—from the moment a patient first reports to the emergency room (ER) through to the time…
SVS Foundation board approves latest pilot programs to help underserved
The SVS Foundation has awarded grants to two Society for Vascular Surgery (SVS) members to help them serve the underserved as part of the Vascular Care for the Underserved program—the initiative formerly known as VISTA (Vascular Volunteers In Service To…
PRELUDE-BTK subanalysis highlights superior lumen gain, greater volumetric blood flow using serration angioplasty
Cagent Vascular has announced the results of a comparative subanalysis of the PRELUDE-below-the-knee (BTK) study versus plain balloon angioplasty. The study was led by Marianne Brodmann, MD, from Medical University of Graz in Graz, Austria. This subanalysis compared their PRELUDE-BTK…
NIH funding for vascular surgeon-scientists: ‘We need more funded vascular surgeons and better coverage of SVS priorities’
Presenting at the 2023 Southern Association for Vascular Surgery (SAVS) annual meeting in Rio Grande, Puerto Rico, Amin A. Mirzaie—a pre-medical student at Emory University in Atlanta—offered observations on the National Institutes of Health’s (NIH) “modestly” aligned vascular surgical funding…
The year in review: 2022 was an amazing 12 months for SVS
Despite any number of challenges, the Society for Vascular Surgery (SVS) had a hugely successful 2022 and looks forward to a bright 2023. Executive Director Kenneth M. Slaw, PhD, outlined a number of firsts for the Society, including: The year…